Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Domain Therapeutics' biased PAR2 inhibitors show antiarthritic effects

June 11, 2020

AbbVie reports new phase IIa data on ABBV-3373 in moderate to severe rheumatoid arthritis

June 11, 2020

Modified peptides generate RA-specific CD4+ T cells with lytic properties against APCs

June 11, 2020

Dual JAK1/TYK2 inhibitor TLL-018 shows dose-dependent anti-inflammatory activity in arthritis models

June 10, 2020

Momelotinib shows efficacy in RA and RA-induced anemia in preclinical rodent models

June 9, 2020

FDA clears IND application for BX-U001 in rheumatoid arthritis

June 8, 2020

Kezar reports updated phase Ib findings on KZR-616 in SLE

June 4, 2020

MAP3K5 inhibitors discovered at Enanta Pharmaceuticals

June 3, 2020

FDA approves Taltz for active nonradiographic axial spondyloarthritis

June 2, 2020

Olokizumab obtains first approval in Russia

June 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...